TScan Therapeutics
Latest round
- Series C
Last raised
- Jan 2021
Total raised
- $158M
Investors
- 10
About TScan Therapeutics
Founded in 2018 and based in Massachusetts, US, TScan Therapeutics, Inc. is a biopharmaceutical company focusing on the development of T-cell receptors (TCR) for the treatment of cancer and tumors. The company was founded by Lea Hachigian and Tomasz Kula. David Southwell serves as the CEO of TScan Therapeutics, Inc. In December 2024, TScan Therapeutics, Inc. The company's product uses the target ID platform to identify the natural targets of tumor-reactive T cells and identify therapeutically active TCRs. TCR-T therapies are being developed by TScan Therapeutics for the treatment of hematological and solid tumors. In 2017, the FDA approved the CAR T-cell therapies tisagenlecleucel (KymriahTM) and axicabtagene ciloleucel (YescartaTM) for the treatment of B-cell acute lymphoblastic leukemia and large B-cell lymphoma in patients with B-cell acute lymphoblastic leukemia. In April 2024, TScan Therapeutics, Inc.13 per share on the Nasdaq Global Select Market under the ticker symbol "TCRX". TScan Therapeutics, Inc.16 million shares of common stock as part of the listing.
Who invested in TScan Therapeutics
10 investors across 3 rounds
See all investors in TScan Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TScan Therapeutics
Who invested in TScan Therapeutics?
TScan Therapeutics has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TScan Therapeutics raised?
TScan Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did TScan Therapeutics last raise money?
TScan Therapeutics's most recent round on record is a Series C, in Jan 2021.
What does TScan Therapeutics do?
Founded in 2018 and based in Massachusetts, US, TScan Therapeutics, Inc.
Where is TScan Therapeutics headquartered?
TScan Therapeutics is headquartered in Waltham, US.
Which VCs invest in companies like TScan Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at TScan Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like TScan Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.